A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals

Treatment of Patients with Serious Infections Due to Carbapenem‐resistant Acinetobacter baumannii : How Viable are the Current Options?

(2021) J Nicholas O’Donnell et al.   PHARMACOTHERAPY

Early Experience with Eravacycline for Complicated Infections

(2020) S Alosaimy et al.   Open Forum Infectious Diseases

In vitro activity of eravacycline against common ribotypes of Clostridioides difficile

(2020) Eugénie Bassères et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies

(2020) Vanessa Grant-Di Felice et al.   Surgical Infections

Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits

(2018) Vidmantas Petraitis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults

(2018) Megan K. Luther et al.   CRITICAL CARE MEDICINE

In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii

(2018) Harald Seifert et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections

(2018) Joseph S Solomkin et al.   CLINICAL INFECTIOUS DISEASES

1978. Efficacy of Eravacycline in Secondary Bacteremia: A Post Hoc Analysis of Two Phase 3 studies of Complicated Intra-Abdominal Infection

(2018) Kenneth Lawrence et al.   Open Forum Infectious Diseases

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

(2017) Joseph Solomkin et al.   JAMA Surgery

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

(2016) George G. Zhanel et al.   DRUGS

Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women

(2014) Kevin P. Connors et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY